nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AML—is it time to drive a CAR(-T)?
|
Rudzki, Jakob D. |
|
|
13 |
1 |
p. 50-54 |
artikel |
2 |
CAR-T cells in multiple myeloma: current status
|
Steiner, Normann |
|
|
13 |
1 |
p. 43-49 |
artikel |
3 |
CAR T-cell therapy in diffuse large B-cell lymphoma
|
Hopfinger, Georg |
|
|
13 |
1 |
p. 32-35 |
artikel |
4 |
CAR(-T)s are on the road
|
Rudzki, Jakob D. |
|
|
13 |
1 |
p. 3-4 |
artikel |
5 |
Complete remission of disseminated Langerhans cell sarcoma after stem cell transplantation
|
Schlintl, Verena |
|
|
13 |
1 |
p. 102-105 |
artikel |
6 |
Cutaneous squamous cell carcinoma
|
Seidl-Philipp, Magdalena |
|
|
13 |
1 |
p. 106-110 |
artikel |
7 |
End-of-life therapy: palliative care instead of palliative scare
|
Masel, Eva Katharina |
|
|
13 |
1 |
p. 7-8 |
artikel |
8 |
Ensuring center quality, proper patient selection and fair access to chimeric antigen receptor T-cell therapy: position statement of the Austrian CAR-T Cell Network
|
Greinix, Hildegard T. |
|
|
13 |
1 |
p. 27-31 |
artikel |
9 |
Epidemiology and predictors of survival of tongue cancer among Egyptians in the Delta region
|
Hamdy, Omar |
|
|
13 |
1 |
p. 118-125 |
artikel |
10 |
Epidemiology of polycythemia vera in a Mexican population
|
Olivas-Martinez, Antonio |
|
|
13 |
1 |
p. 111-117 |
artikel |
11 |
Evidence-based follow-up
|
Wöll, Ewald |
|
|
13 |
1 |
p. 5-6 |
artikel |
12 |
Evidence-based follow-up for breast cancer
|
Stierer, Michael |
|
|
13 |
1 |
p. 60-63 |
artikel |
13 |
Evidence-based follow-up in colorectal cancer—quo vadis?
|
Maglione, Manuel |
|
|
13 |
1 |
p. 64-68 |
artikel |
14 |
Evidence-based follow-up in lung cancer?
|
Ng, Caecilia |
|
|
13 |
1 |
p. 73-77 |
artikel |
15 |
Evidence-based follow-up in non-small cell lung cancer
|
Watzka, Stefan B. |
|
|
13 |
1 |
p. 69-72 |
artikel |
16 |
Evidence-based follow-up in patients with Hodgkin’s lymphoma and aggressive B-cell non-Hodgkin’s lymphoma
|
Spanberger, Thomas |
|
|
13 |
1 |
p. 55-59 |
artikel |
17 |
Evidence-based follow-up in renal cell carcinoma
|
Mayrhofer, Karl |
|
|
13 |
1 |
p. 78-83 |
artikel |
18 |
Importance of avoiding late cancer-directed therapy in terminally ill cancer patients
|
Jahn-Kuch, Daniela |
|
|
13 |
1 |
p. 84-87 |
artikel |
19 |
Incidental thyroid papillary microcarcinoma on 1777 surgically treated patients for benign thyroid disease
|
Peluso, Gaia |
|
|
13 |
1 |
p. 126-133 |
artikel |
20 |
Palliative sedation for delirium management at the end of life
|
Roider-Schur, Sophie |
|
|
13 |
1 |
p. 93-97 |
artikel |
21 |
Role of CAR-T cell therapy in B-cell acute lymphoblastic leukemia
|
Greinix, Hildegard T. |
|
|
13 |
1 |
p. 36-42 |
artikel |
22 |
The golden anniversary of the Austrian Society of Hematology and Medical Oncology (OeGHO)
|
Hilbe, Wolfgang |
|
|
13 |
1 |
p. 1-2 |
artikel |
23 |
The top ten things that must be known about end of life therapy in patients with advanced cancer
|
Kreye, Gudrun |
|
|
13 |
1 |
p. 88-92 |
artikel |
24 |
The 2020 update of the recommendations of the Austrian working group on lung pathology and oncology for the diagnostic workup of non-small cell lung cancer with focus on predictive biomarkers
|
Popper, Helmut H. |
|
|
13 |
1 |
p. 11-26 |
artikel |
25 |
While I breathe, I hope. Principles of palliative care in chronic breathlessness and advanced lung diseases
|
Masel, Eva Katharina |
|
|
13 |
1 |
p. 98-101 |
artikel |
26 |
Young hematologists and medical oncologists in focus
|
Kiesewetter, Barbara |
|
|
13 |
1 |
p. 9-10 |
artikel |